Loss of prdm1a accelerates melanoma onset and progression.
Saved in:
| Title: | Loss of prdm1a accelerates melanoma onset and progression. |
|---|---|
| Authors: | Iwanaga R; Department of Craniofacial Biology, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado., Truong BT; Department of Craniofacial Biology, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado.; Human Medical Genetics & Genomics Graduate Program, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado., Hsu JY; Pharmacology Graduate Program, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado., Lambert KA; Department of Dermatology, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado., Vyas R; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts., Orlicky D; Department of Pathology, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado., Shellman YG; Department of Dermatology, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado., Tan AC; Division of Medical Oncology, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado., Ceol C; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts., Artinger KB; Department of Craniofacial Biology, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado. |
| Source: | Molecular carcinogenesis [Mol Carcinog] 2020 Sep; Vol. 59 (9), pp. 1052-1063. Date of Electronic Publication: 2020 Jun 20. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8811105 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-2744 (Electronic) Linking ISSN: 08991987 NLM ISO Abbreviation: Mol Carcinog Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
